Ranbaxy's statin a drag on PPD's bottom line
PPD's decision to in-license an investigational compound is proving to be a drag on its bottom line as the firm continues to seek a development partner for the drug.
Archives for October 29, 2007
Major Singapore investment for Novartis
Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
Weekly Comment
Big pharma lends a helping hand
Despite often attracting a barrage of negative publicity, particularly in regard to a perception of putting profits before people, big pharma firms are still capable of showing their human side in times of crisis.
Gene therapy offers protection from terrorist attack
A gene therapy has shown it could protect vital organs from the damaging effects of ionising radiation during a terrorist attack.